{"schema_version":"secwatch.filing_event.v1","accession":"0001801170-24-000182","form_type":"8-K","ticker":"CLOV","cik":"0001801170","company_name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","filed_at":"2024-08-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.563286+00:00","generated_at":"2026-05-31T08:06:34.177356+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Clover Health appoints former Molina Healthcare CFO Thomas L. Tran to Board and Audit Committee","bullets":["Thomas L. Tran appointed Class II director and Audit Committee member; Board expanded from 8 to 9.","Tran brings 35+ yrs healthcare finance experience; was CFO of Molina Healthcare (2018-2021) and Upstream Care (2022-2023).","Tran receives pro-rated annual retainer and $200K RSU award for 2024 service under Clover's director compensation policy.","Tran entered standard indemnification agreement; no arrangements or family relationships with officers/directors."],"urls":{"canonical":"https://secwatch.observer/filing/0001801170-24-000182","json":"https://secwatch.observer/filing/0001801170-24-000182.json","markdown":"https://secwatch.observer/filing/0001801170-24-000182.md","text":"https://secwatch.observer/filing/0001801170-24-000182.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1801170/000180117024000182/0001801170-24-000182-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1801170/000180117024000182/clov-20240820.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T08:06:34.177356+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"f8100c715c","claim":"Thomas L. Tran was appointed as Class II director at CLOVER HEALTH INVESTMENTS, CORP. /DE.","evidence_excerpt":"On August 20, 2024, the Board of Directors (the \"Board\") of Clover Health Investments, Corp. (\"Clover\" or the \"Company\") appointed Thomas L. Tran, to serve as a Class II director of the Board.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117024000182/0001801170-24-000182-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Class II director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}